Brennan, Daniel C.

International trial of the Edmonton protocol for islet transplantation

Shapiro, A. M. J., Ricordi, C., Hering, B. J., Auchincloss, H., Lindblad, R., Robertson, R. P., Secchi, A., Brendel, M. D., Berney, T., Brennan, D. C., et al. (2006) · New England Journal of Medicine

Pancreatic function and diabetesDiabetes and associated disorders

Cited by 1,942

Long-Term Follow-Up of the Edmonton Protocol of Islet Transplantation in the United States

Brennan, D. C., Kopetskie, H. A., Sayre, P. H., Alejandro, R., Cagliero, E., Shapiro, A. M. J., Goldstein, J. S., DesMarais, M. R., Booher, S., & Bianchine, P. J. (2016) · American Journal of Transplantation

Pancreatic function and diabetesDiabetes and associated disorders

Cited by 176

Who Can Tolerate a Marginal Kidney? Predicting Survival after Deceased Donor Kidney Transplant by Donor-Recipient Combination

Bae, S., Massie, A. B., Thomas, A. G., Bahn, G., Luo, X., Jackson, K. R., Ottmann, S. E., Brennan, D. C., Desai, N. M., Coresh, J., et al. (2019) · American Journal of Transplantation

Renal Transplantation Outcomes and TreatmentsOrgan Donation and Transplantation

Cited by 138

Results of ASERTAA, a Randomized Prospective Crossover Pharmacogenetic Study of Immediate-Release Versus Extended-Release Tacrolimus in African American Kidney Transplant Recipients

Trofe-Clark, J., Brennan, D. C., West-Thielke, P., Milone, M. C., Lim, M. A., Neubauer, R., Nigro, V., & Bloom, R. D. (2018) · American Journal of Kidney Diseases

Renal Transplantation Outcomes and TreatmentsPharmacogenetics and Drug Metabolism

Cited by 93

Chronopharmacokinetics and Food Effects of Single-Dose LCP-Tacrolimus in Healthy Volunteers

Alloway, R. R., Trofe-Clark, J., Brennan, D. C., Kerr, J., Cohen, E. A., Meier-Kriesche, U., Stevens, D. R., Moten, M. A., & Momper, J. D. (2020) · Therapeutic Drug Monitoring

Renal Transplantation Outcomes and TreatmentsPharmacogenetics and Drug Metabolism

Cited by 10